Physician

Marina Gilca, MD

According to 2025 Medicare claims, Marina Gilca, MD (NPI: 1386028314) practices ophthalmology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LTD (NPI: 1972589182; TIN: 450408552) and primary practice location at 58104-4556.

Gilca's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,300 traditional Medicare patients, billed 122,030 HCPCS/CPT codes, and received $5,294,570 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 736 prescription claims across 290 beneficiaries totaling $32,320 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 22 records totaling $15,932. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,875 to $5,294,570. Similarly, Part D prescription costs have risen steadily, from $871 to $32,320. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.3M2015 Medicare payment: $5,875 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $39,860 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $473,125 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,153,953 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,622,844 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,869,349 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,757,706 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,482,675 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,344,208 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,294,570 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153441$5,875
2016188410$39,860
20173891,819$473,125
20185548,027$2,153,953
201986515,577$3,622,844
202091116,684$3,869,349
202191513,885$3,757,706
202290123,384$3,482,675
20231,09689,570$4,344,208
20241,300122,030$5,294,570

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $871 (USD; Tot_Drug_Cst)2016 Drug cost: $2,761 (USD; Tot_Drug_Cst)2017 Drug cost: $5,782 (USD; Tot_Drug_Cst)2018 Drug cost: $21,252 (USD; Tot_Drug_Cst)2019 Drug cost: $32,923 (USD; Tot_Drug_Cst)2020 Drug cost: $34,613 (USD; Tot_Drug_Cst)2021 Drug cost: $28,926 (USD; Tot_Drug_Cst)2022 Drug cost: $25,129 (USD; Tot_Drug_Cst)2023 Drug cost: $33,526 (USD; Tot_Drug_Cst)2024 Drug cost: $32,320 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151218$871
20162353$2,761
20172979$5,782
2018101351$21,252
2019193727$32,923
2020215807$34,613
2021184683$28,926
2022182506$25,129
2023244624$33,526
2024290736$32,320

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more388388$125
67028Injection of drug into eye6882,624$99
92014Established patient complete exam of visual system679831$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more400695$70
92134Imaging of retina1,2193,350$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol19800$5,710
Prednisolone AcetatePrednisolone Acetate1024,186$5,650
Bromfenac SodiumBromfenac Sodium17577$4,197
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1833,651$2,398
DifluprednateDifluprednate15365$2,297

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$535Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$15,397Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marina Gilca, MD?

Tedicare shows public-source Medicare data for Marina Gilca, MD (NPI 1386028314), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marina Gilca, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marina Gilca, MD?

Marina Gilca, MD is linked to RETINA CONSULTANTS, LTD (billing NPI 1972589182) in the available physician profile data.

Does Marina Gilca, MD have Open Payments data?

Marina Gilca, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.